The effects of becoming an entrepreneur on the use of psychotropics among entrepreneurs and their spouses

Scandinavian Journal of Public Health

Volumn 38, Issue 8, 2010, Pages 857-863

  Dahl, Michael S ^a   Nielsen, Jimmi ^b   Mojtabai, Ramin ^c  

^a AALBORG UNIVERSITY   (Denmark)

^b Aalborg Psykiatriske Sygehus   (Denmark)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Entrepreneurship; psychotropic drugs; stress; work load

Indexed keywords

ANTIDEPRESSANT AGENT; HYPNOTIC SEDATIVE AGENT; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; COMMERCIAL PHENOMENA; DENMARK; DRUG UTILIZATION; FEMALE; HUMAN; MALE; MENTAL STRESS; MIDDLE AGED; PRESCRIPTION; PSYCHOLOGICAL ASPECT; REGISTER; SOCIOECONOMICS; SPOUSE; STATISTICS; WORKLOAD;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DENMARK; DRUG PRESCRIPTIONS; DRUG UTILIZATION; ENTREPRENEURSHIP; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; PSYCHOTROPIC DRUGS; REGISTRIES; SEROTONIN UPTAKE INHIBITORS; SOCIOECONOMIC FACTORS; SPOUSES; STRESS, PSYCHOLOGICAL; WORKLOAD;

EID: 78650478185     PISSN: 14034948     EISSN: None     Source Type: Journal    
DOI: 10.1177/1403494810375490     Document Type: Article

References (28)

1. Delmar F., Davidsson P. Where do they come from? Prevalence and characteristics of nascent entrepreneurs. Entrepreneurship and Reg Dev 2000;12(1):1-23.
2. Hytti U. New meanings for entrepreneurs: from risk-taking heroes to safe-seeking professsionals. J Organiz Change Manage 2005;18(6):594-611.
3. Jalovaara M. Socio-economic status and divorce in first marriages in Finland 1991-93. Population Studies 2001;55(2):119-133.
4. Harris J.A., Saltstone R., Fraboni M. An evaluation of the job stress questionnaire with a sample of entrepreneurs. J Business and Psychol 1999;13(3):447-455.
5. Verheul I., Thurik R. Start-up capital: does gender matter? Small Business Economics 2001;16(4):329-346.
6. Taylor M.P. The survival of the fittest: an analysis of self-employment duration in Britain. Economic J 1999; 109 (March):C140-C155.
7. Dahl M., Reichstein T. Are you experienced? Prior experience and the survival of new organizations. Industry and Innovation 2007;14(5):497-511.
8. Freeman J., Carroll G.R., Hannan M.T. The liability of newness: age dependence in organizational death rates. Am Sociol Rev 1983;48(5):692-710.
9. Checkley S. The neuroendocrinology of depression and chronic stress. Br Med Bull 1996;52(3):597-617.
10. Krantz G., Berntsson L., Lundberg U. Total workload, work stress and perceived symptoms in Swedish male and female white-collar employees. Eur J Public Health 2005; 15(2):209-214.
11. Rugulies R., Bultmann U., Aust B., Burr H. Psychosocial work environment and incidence of severe depressive symptoms: prospective findings from a 5-year follow-up of the Danish work environment cohort study. Am J Epidemiol 2006;163(10):877-887.
12. Melchior M., Caspi A., Milne B.J., Danese A., Poulton R., Moffitt T.E. Work stress precipitates depression and anxiety in young, working women and men. Psychol Med 2007;37(8):1119-1129.
13. Sørensen J. Bureacracy and entrepreneurship: workplace effects on entrepreneurial entry. Admin Sci Quart 2007;52(3):387-412.
14. World Health Organization. World Health Organization, collaborating centre. Drug Statistics Methodology; 2007.
15. Pelfrene E., Vlerick P., Moreau M., Mak R.P., Kornitzer M., De Backer G. Use of benzodiazepine drugs and perceived job stress in a cohort of working men and women in Belgium. Results form the BELSTRESS-study. Social Sci Med 2004;59:433-442.
16. Virtanen M., Honkonen T., Kivimaki M., Ahola K., Vahtera J., Aromaa A., Lonnqvist J. Work stress, mental health and antidepressant medication findings from the Health 2000 Study. J Affect Disord 2007;98(3):189-197.
17. Wieclaw J., Agerbo E., Mortensen P.B., Burr H., Tuchsen F., Bonde J.P. Psychosocial working conditions and the risk of depression and anxiety disorders in the Danish workforce. BMC Public Health 2008;8:280.
18. Sørensen J., Sorenson O. From conception to birth: opportunity perception and resource mobilization. Adv Strat Manage 2003;20:89-117.
19. Harada N. Who succeeds as an entrepreneur? An analysis of the post-entry performance of new firms in Japan. Japan and the World Economy 2003;15(2):211-222.
20. Bennett R., Dann S. The changing experience of Australian female entrepreneurs. Gender, Work and Organization 2000;7(2):75-83.
21. Lader M. Effectiveness of benzodiazepines: do they work or not? Expert Rev Neurother 2008;8(8):1189-1191.
22. McEwen B.S. Protective and damaging effects of stress mediators. N Engl J Med 1998;338(3):171-9.
23. Kivimaki M., Honkonen T., Wahlbeck K., Elovainio M., Pentti J., Klaukka T., et al. Organisational downsizing and increased use of psychotropic drugs among employees who remain in employment. J Epidemiol Community Health 2007;61(2):154-8.
24. Kivimaki M., Vahtera J., Pentti J., Ferrie J.E. Factors underlying the effect of organisational downsizing on health of employees: longitudinal cohort study. BMJ 2000;320(7240):971-5.
25. Westerlund H., Ferrie J., Hagberg J., Jeding K., Oxenstierna G., Theorell T. Workplace expansion, long-term sickness absence, and hospital admission. Lancet 2004;363(9416): 1193-7.
26. Cameron L., Leventhal E.A., Leventhal H. Seeking medical care in response to symptoms and life stress. Psychosom Med 1995;57(1):37-47.
27. Byrne N., Regan C., Howard L. Administrative registers in psychiatric research: a systematic review of validity studies. Acta Psychiatr Scand 2005;112(6):409-414.
28. Parker G. Register now: validity later. Acta Psychiatr Scand 2005;112(6):407-8.